Rifabutin

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 07.10.2021

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Tuberculostatics, chemotherapy.

IndicationThis section has been translated automatically.

Tuberculosis, infections by atypical mycobacteria (MAI), prophylaxis of MAI infection in HIV patients with < 200 CD4 cells/μl.

Limited indicationThis section has been translated automatically.

Pregnancy, lactation, children < 14 years, severe liver and kidney failure.

Dosage and method of useThis section has been translated automatically.

Tuberculosis (combination therapy): 150 mg/day p.o., in case of immunosuppression 300 mg/day p.o.

MAI: 300 mg/day p.o. for up to 6 months after achieving negative cultures; in combination with clarithromycin, other macrolides or triazole antifungals 300 mg/day. In combination with indinavir: 150 mg/day p.o.

MAI prophylaxis: 300 mg/day p.o.

Reminder. Patients with soft contact lenses must be informed about the possibility of permanent discolouration of the lenses!

Undesirable effectsThis section has been translated automatically.

Allergic reactions, skin discoloration and discoloration of body excretions after red-orange, headaches, sleep disorders, uveitis, chest pain, anemia, eosinophilia, leukopenia, neutropenia, thrombopenia, abdominal pain, myalgias.

InteractionsThis section has been translated automatically.

See Table 1.

ContraindicationThis section has been translated automatically.

Rifamycin hypersensitivity, acute hepatitis or cirrhosis of the liver, occlusive scterus, thrombocytopenia.

PreparationsThis section has been translated automatically.

Mycobutin

TablesThis section has been translated automatically.

Major interactions of rifabutin

Quinidine

Quinidine effect ↓

Clarithromycin

Rifabutin toxicity (plasma levels around 80% ↑, possibly dose reduction).

Cotrimoxazole

Cotrimoxazole effect ↓

Coumarins

Coumarin effect ↓

Dapsone

Dapsone effect ↓

Didanosine

Palpitations, tachycardia

Fluconazole

Rifabutin levels around 80% ↑, possible dose adjustment.

Glucocorticoids

Glucocorticoid effect ↓

Cardiac glycosides

Cardiac glycoside effect ↓

Contraceptives, oral

contraceptive effect ↓

L-methadone

L-methadone effect ↓

Opioids

Opioid effect ↓

Phenytoin

Phenytoin effect ↓

Sulfonylureas

Sulfonylurea effect ↓

Authors

Last updated on: 07.10.2021